US Patent

US8733341 — Atomizer and method of atomizing fluid with a nozzle rinsing mechanism

Formulation · Assigned to Boehringer Ingelheim International GmbH · Expires 2030-10-16 · 4y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects an atomizer and method for dispensing and atomizing fluid into individual containers with improved dosing accuracy through a nozzle rinsing mechanism.

USPTO Abstract

An atomizer and a method of dispensing and atomizing fluid into individual containers through a nozzle are proposed, where in order to improve the dosing accuracy, a preliminary amount of fluid, flushing the nozzle, is dispensed before each dose is dispensed.

Drugs covered by this patent

olodaterol-hydrochloride (OLODATEROL HYDROCHLORIDE)
albuterol-sulfate (ALBUTEROL SULFATE)
Spiriva (TIOTROPIUM BROMIDE) · Boehringer Ingelheim

Patent Metadata

Patent number: US8733341
Jurisdiction: US
Classification: Formulation
Expires: 2030-10-16
Drug substance claim: No
Drug product claim: Yes
Assignee: Boehringer Ingelheim International GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.